April 2010 Allergy & Asthma
The Coalition for Community Pharmacy Action (CCPA) has been working toward ensuring that health care reform legislation favors community pharmacies-included here are some top issues and when the change will take effect.
Although the demand for generic competition in the biopharmaceutical market could potentially be great, regulators have been slow to clear a pathway for the approval of generic biopharmaceuticals.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
2
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
3
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
4
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
5
